Navigation Links
Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments
Date:8/3/2009

SAN DIEGO, Aug. 3, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported financial results for the second quarter ended June 30, 2009.

Arena reported a lower net loss allocable to common stockholders in the second quarter of 2009 of $38.0 million, or $0.48 per share, compared to a net loss allocable to common stockholders in the second quarter of 2008 of $65.8 million, or $0.89 per share, and a net loss allocable to common stockholders in the first half of 2009 of $88.6 million, or $1.16 per share, compared to a net loss allocable to common stockholders in the first half of 2008 of $120.8 million, or $1.64 per share.

"We are on track to announce results from the BLOSSOM trial in September, which we expect will be the final piece of lorcaserin's NDA that we plan to submit by the end of this year," stated Jack Lief, Arena's President and Chief Executive Officer. "Based on its emerging efficacy, safety and tolerability profile, lorcaserin has the potential to be an important new treatment option for patients needing to better manage their weight and improve their overall health. Our improved financial position strengthens our ability to obtain marketing approval for lorcaserin and our position in partnership discussions."

As expected, research and development expenses declined significantly to $24.2 million in the second quarter of 2009 from $56.2 million in the second quarter of 2008. Research and development expenses declined to $66.8 million in the first half of 2009 from $103.6 million in the first half of 2008. This decrease primarily resulted from decreased clinical trial costs due to the completion of clinical and preclinical studies as Arena prioritized its spending towards activities that support filing a New Drug Ap
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Arena Pharmaceuticals Announces Public Offering of Common Stock
3. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
4. Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Arena Pharmaceuticals Lorcaserin for Obesity Passes Major Safety Milestone
7. Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
8. Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008
9. Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena
10. Childrens Miracle Network and Arena Football League Partner for First Nationwide Celebration Event
11. Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... 2015 Aureus Medical Group (web: ... physical therapy jobs, has announced that it will ... Therapy Association Annual Conference to be held April ... in Columbus, OH. , The OPTA Annual ... with products and services. , Representatives from ...
(Date:3/28/2015)... ARDX will sponsor the 7th Annual Women’s Wellness Celebration on ... Center in Chesapeake, Virginia. Each year, ARDX celebrates Women’s ... the Hampton Roads region. The 2015 Women’s History Month ... grow stronger through sharing their stories and learning the strategies ... theme is T-talk where we will share a cup of ...
(Date:3/27/2015)... The Monogamy Method - ... Sanderson and Jason Rogers has just been released to ... The commotion surrounding the course's launch has caught the ... an in-depth review of the new program. , "Many ... their lives suddenly start pulling away or expressing interest ...
(Date:3/27/2015)... 27, 2015 The federal court overseeing ... the statin medication increases the risk that a patient ... Motion to Dismiss four individual cases that had been ... Order issued in the U.S. District Court, District of ... the dismissals were warranted because the plaintiffs in those ...
(Date:3/27/2015)... Healthpointe is proud to announce that board-certified ... treating knee and hip joint disorders in practice locations ... and La Mirada. Dr. Stanley Katz specializes in the ... disorders as well as chronic conditions such as arthritis. ... patients back to their normal lives. Many of ...
Breaking Medicine News(10 mins):Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:The Monogamy Method - Review Of Samantha Sanderson & Jason Rogers' Relationship Program Released 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 3Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 2Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 3
... Diseases, a unique initiative that brings together researchers, ... to focus research and expertise on this growing ... at the London School of Hygiene & Tropical ... diabetes, cardiovascular disease and chronic respiratory disease have ...
... , TUESDAY, April 24 (HealthDay News) -- Heart ... but does not change in women, a small new study ... likely than men to have heart trouble when they suffer ... The investigators measured heart rate, blood pressure and heart ...
... Nearly 8 of 10 Americans will experience lower ... Persistent low back pain is a common, incapacitating, ... might benefit significantly from an individualized, multidisciplinary, team-based ... complementary care practitioners (e.g., chiropractors, massage therapists, and ...
... By Steven Reinberg HealthDay Reporter , MONDAY, ... 74 percent worldwide between 2000 and 2010, but progress ... health officials reported Monday. "This is one of ... health," said Anthony Lake, executive director of the United ...
... Toxic prions in the brain can be detected with ... has now shown that the same molecules can also ... illnesses. Linkping researchers and their colleagues at the ... or LCPs, on tissue sections from the brains of ...
... Dr. Niel Crews, assistant professor of mechanical engineering at ... for Micromanufacturing, has been awarded an Early Career Development ... proposal, "Thermal Gradient Microflow Calorimetry using Anisotropic Temperature Sensors." ... the scope of his research program and also integrate ...
Cached Medicine News:Health News:Centre for Global Non-Communicable Diseases launched to tackle killer diseases 2Health News:Stress May Be Tougher on Women's Hearts Than Men's: Study 2Health News:Measles Deaths Falling Worldwide 2Health News:Measles Deaths Falling Worldwide 3Health News:Prions in the brain eliminated by homing molecules 2Health News:Louisiana Tech University professor earns NSF Early Career Development grant 2
(Date:3/27/2015)...   Hospira, Inc. (NYSE: HSP ... world,s leading provider of injectable drugs and infusion ... of biosimilarity of its proposed biosimilar, Epoetin Hospira, ... conditionally approved name of RETACRIT™, compared to the ... data were presented at the National Kidney Foundation ...
(Date:3/27/2015)...  Delcath Systems, Inc. (NASDAQ: DCTH ), ... on oncology with an emphasis on the treatment ... reporting of data from a single -center experience ... the Delcath Hepatic Delivery System (Melphalan/HDS) and other ... of Surgical Oncology (SSO) Annual Meeting 2015.  The ...
(Date:3/26/2015)... /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the ... Omega-3 therapies for cardiovascular disease and overall health, announced ... shares of the Corporation (the "Common Shares"). The Common ... December 5 th , 2014 to March 4 th ... due on or before April 1, 2015. Interest on ...
Breaking Medicine Technology:Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
... 2010 As families gather for the holidays ... and their caregivers to make family health part ... to know one,s family health history, it,s also ... care and best ways to manage heath care ...
... Reportlinker.com announces that a new market research ... Global Medical Oxygen Systems Industry ... analyzes the worldwide markets for Medical Oxygen Systems ... Concentrators, Liquid Oxygen Systems, Oxygen Cylinders & Regulators, ...
Cached Medicine Technology:CVS/pharmacy Helps Seniors Evaluate Medicare Part D Options and Identify Potential Ways to Save on Prescription Drugs in 2011 2Reportlinker Adds Global Medical Oxygen Systems Industry 2Reportlinker Adds Global Medical Oxygen Systems Industry 3Reportlinker Adds Global Medical Oxygen Systems Industry 4Reportlinker Adds Global Medical Oxygen Systems Industry 5Reportlinker Adds Global Medical Oxygen Systems Industry 6Reportlinker Adds Global Medical Oxygen Systems Industry 7Reportlinker Adds Global Medical Oxygen Systems Industry 8Reportlinker Adds Global Medical Oxygen Systems Industry 9Reportlinker Adds Global Medical Oxygen Systems Industry 10Reportlinker Adds Global Medical Oxygen Systems Industry 11Reportlinker Adds Global Medical Oxygen Systems Industry 12Reportlinker Adds Global Medical Oxygen Systems Industry 13Reportlinker Adds Global Medical Oxygen Systems Industry 14Reportlinker Adds Global Medical Oxygen Systems Industry 15Reportlinker Adds Global Medical Oxygen Systems Industry 16
... HydroTech vacuum pump is perfect for electrophoresis ... a continuous vacuum of greater than 29 ... works very well with the Model 583 ... fittings for 1/4 and 3/8 inch ID ...
For vacuum-driven processing of spin columns; Reduced sample handling and accelerated processing; Parallel sample processing using QIAGEN spin columns; Easy cleaning of internal components by simpl...
Inquire...
... Vac Manifold is available to ... 30 minutes; the manifold is ... and a vacuum regulator with ... vacuum chamber, on/off switch, control ...
Medicine Products: